Table of Contents
Vitamins and Dietary Supplements in Brazil
Euromonitor International
May 2009
List of Contents and Tables
Executive Summary
Positive
Economy Indicators Push Sales of OTC Healthcare
New Rules for OTC
Advertising
Hypermarcas Acquires Dm Indústria Farmacêutica and
Farmasa
Further Consolidation of Drugstores
Slowdown Growth in the
Next Two Years
Key Trends and Developments
Further Restriction To
Advertising of OTC Products
Hypermarcas Acquires Two Leading OTC
Manufacturers
Specific Department for OTC Products Established Within
Anvisa
Financial Crisis Affects OTC Products
Senior Consumers and
Women Over 40 Years Old Attract Investment
Market Indicators
Table 1
Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table
2 Life Expectancy at Birth 2003-2008
Market Data
Table 3 Sales of OTC
Healthcare by Sector: Value 2003-2008
Table 4 Sales of OTC Healthcare by
Sector: % Value Growth 2003-2008
Table 5 OTC Healthcare Company Shares by
Value 2004-2008
Table 6 OTC Healthcare Brand Shares by Value 2005-2008
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis
2003-2008
Table 8 Sales of OTC Healthcare by Sector and Distribution
Format: % Analysis 2008
Table 9 Forecast Sales of OTC Healthcare by
Sector: Value 2008-2013
Table 10 Forecast Sales of OTC Healthcare by
Sector: % Value Growth 2008-2013
Appendix
OTC Registration and
Classification
De-reimbursement
Advertising
Packaging and
Labelling
Distribution
Vitamins and Dietary Supplements Registration
and Classification
Self-medication and Preventative Medicine
Generics
Switches
Summary 1 OTC Healthcare Switches 2005-2007
Definitions
Summary 2 Research Sources
Aché Laboratórios
Farmacêuticos SA
Strategic Direction
Key Facts
Summary 3
Aché Laboratórios Farmacêuticos SA: Key Facts
Summary 4
Aché Laboratórios Farmacêuticos SA: Operational Indicators
Company Background
Production
Summary 5 Aché Laboratórios
Farmacêuticos SA: Production Statistics 2007
Competitive
Positioning
Summary 6 Aché Laboratórios Farmacêuticos SA:
Competitive Position 2008
Bayer SA
Strategic Direction
Key
Facts
Summary 7 Bayer SA: Key Facts
Summary 8 Bayer SA: Operational
Indicators
Company Background
Production
Competitive
Positioning
Summary 9 Bayer SA: Competitive Position 2008
Boehringer
Ingelheim Do Brasil Química E Farmacêutica Ltda
Strategic
Direction
Key Facts
Summary 10 Boehringer Ingelheim do Brasil
Química e Farmacêutica Ltda: Key Facts
Summary 11 Boehringer
Ingelheim do Brasil Química e Farmacêutica Ltda: Operational
Indicators
Company Background
Production
Summary 12 Boehringer
Ingelheim do Brasil Química e Farmacêutica Ltda: Production
Statistics 2007
Competitive Positioning
Summary 13 Boehringer
Ingelheim do Brasil Química e Farmacêutica Ltda: Competitive
Position 2008
Dm Indústria Farmacêutica Ltda
Strategic
Direction
Key Facts
Summary 14 DM Indústria Farmacêutica
Ltda: Key Facts
Summary 15 DM Indústria Farmacêutica Ltda:
Operational Indicators
Company Background
Production
Competitive
Positioning
Summary 16 DM Indústria Farmacêutica Ltda:
Competitive Position 2008
Ems SA
Strategic Direction
Key Facts
Summary 17 EMS SA: Key Facts
Summary 18 EMS SA: Operational Indicators
Company Background
Production
Summary 19 EMS SA: Production Statistics
2007
Competitive Positioning
Summary 20 EMS SA: Competitive Position
2008
Eurofarma Laboratório Ltda
Strategic Direction
Key
Facts
Summary 21 Eurofarma Laboratório Ltda: Key Facts
Summary 22
Eurofarma Laboratório Ltda: Operational Indicators
Company
Background
Production
Summary 23 Eurofarma Laboratório Ltda:
Production Statistics 2007
Competitive Positioning
Summary 24
Eurofarma Laboratório Ltda: Competitive Position 2008
Janssen-cilag
Farmaceutica Ltda
Strategic Direction
Key Facts
Summary 25
Janssen-Cilag Farmacêutica Ltda: Key Facts
Company Background
Production
Competitive Positioning
Summary 26 Janssen-Cilag
Farmacêutica Ltda: Competitive Position 2008
Medley SA Indústria
Farmacêutica
Strategic Direction
Key Facts
Summary 27 Medley
SA Indústria Farmacêutica: Key Facts
Summary 28 Medley SA
Indústria Farmacêutica: Operational Indicators
Company
Background
Production
Summary 29 Medley SA Indústria
Farmacêutica: Production Statistics 2007
Competitive Positioning
Summary 30 Medley SA Indústria Farmacêutica: Competitive Position
2008
Nycomed Pharma Ltda
Strategic Direction
Key Facts
Summary
31 Nycomed Pharma Ltda: Key Facts
Summary 32 Nycomed Pharma Ltda:
Operational Indicators
Company Background
Production
Summary 33
Nycomed Pharma Ltda: Production Statistics 2007
Competitive
Positioning
Summary 34 Nycomed Pharma Ltda: Competitive Position 2008
Sanofi-aventis Farmacêutica Ltda
Strategic Direction
Key
Facts
Summary 35 Sanofi-Aventis Farmacêutica Ltda: Key Facts
Summary 36 Sanofi-Aventis Farmacêutica Ltda: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 37
Sanofi-Aventis Farmacêutica Ltda: Competitive Position 2008
Headlines
Trends
Vitamins
Dietary Supplements
Competitive
Landscape
Prospects
Sector Data
Table 11 Sales of Vitamins and
Dietary Supplements by Subsector: Value 2003-2008
Table 12 Sales of
Vitamins and Dietary Supplements by Subsector: % Value Growth 2003-2008
Table 13 Folic Acid v Other B Vitamins 2004-2008
Table 14 Dietary
Supplements by Positioning 2006-2008
Table 15 Vitamins and Dietary
Supplements Company Shares by Value 2004-2008
Table 16 Vitamins and
Dietary Supplements Brand Shares by Value 2005-2008
Table 17 Vitamins
Brand Shares by Value 2005-2008
Table 18 Dietary Supplements Brand Shares
by Value 2005-2008
Summary 38 Dietary Supplements: Brand Ranking by
Positioning 2008
Table 19 Forecast Sales of Vitamins and Dietary
Supplements by Subsector: Value 2008-2013
Table 20 Forecast Sales of
Vitamins and Dietary Supplements by Subsector: % Value Growth 2008-2013
| 
View Cart
